Searchable abstracts of presentations at key conferences in endocrinology

ea0011s80 | Management of complex genital anomalies and the transition from childhood to adulthood | ECE2006

Management of complex genital anomalies and the transition from childhood to adulthood: A patient’s perspective

Carmichael PA

The way in which children with complex genital anomalies are managed is the subject of controversy and in a state of flux. The practice of early childhood genital surgery has been challenged in relation to both consent issues and functional outcomes.For the past fifty years practice has been informed by the so called optimal gender policy which proposed that in disorders of sexual development (DSD) gender assignment should be that which allows optimal ps...

ea0011p384 | Diabetes, metabolism and cardiovascular | ECE2006

Expression and Localisation of human tissue kallikrein in transfected human embryonic kidney cells (HEK-293). Development of a novel panel of monoclonal antibodies (mAbs) against human tissue kallikrein

Pham YC , Meadows PA , Harvey JN

Tissue kallikrein is a serine protease involved in the generation of kinins in kidneys, colon, salivary glands, pancreas and blood vessels which have vasodilator roles and influence ion transport. Abnormal renal synthesis and urinary excretion of tissue kallikrein have been linked to diabetes and hypertension. This study’s objective was to produce mAbs against native forms of prokallikrein and active kallikrein in order to study the expression of tissue kallikrein in diff...

ea0098c35 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023

Institutional retrospective review of peptide receptor radionuclide therapy use in metastatic paragangliomas and pheochromocytomas

Lan Wong PA-C, Yee , MD, PhD. James Thomas

Background: Metastatic paragangliomas (PGL) and pheochromocytomas (PCC) are rare neuroendocrine diseases with an incidence of 2 to 8 people per million, a prevalence between 1:2500 and 1:6500 and a strong hereditary disposition. However, due to the rarity of the disease, there is relatively limited data on treatment options, including radionuclide therapy using radioisotope analogs of MIBG and dotatate. There are a few published small series on clinical benefits of treating PG...

ea0089c8 | Clinical – Chemo/SSA/Biologics | NANETS2022

Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-Differentiated Neuroendocrine Tumors

Al-Toubah, MPH Taymeyah , Morse, MD Brian , Haider, MD Mintallah , Valone, PA Tiffany , Strosberg, MD Jonathan

Background: Immune checkpoint inhibitors have not been shown to be active in well-differentiated NETs, with response rates <5%. Lenvatinib is a multitargeted TKI which targets VEGF and FGF receptors and has been reported to be effective in pancreatic and gastrointestinal NETs (40% and 18.5% ORR, respectively). The combination of antiangiogenic and checkpoint inhibitor therapies can be synergistic in other cancers. We therefore evaluated the combination of lenvatinib and pe...

ea0063p607 | Diabetes, Obesity and Metabolism 2 | ECE2019

Liver fibrosis and steatosis severity evaluation in patients with chronic hepatitis C and type 2 diabetes mellitus

Irina Morozova , Beliy PA , Axelrod AG , Rodnikova EM , Dudina KR , Safiullina NH , Znoyko OO

Background: Non-alcoholic fatty liver disease and chronic hepatitis C (CHC) are systemic diseases with a broad spectrum of coexisting disorders, but their common features are insulin resistance and higher frequency of concomitant type 2 diabetes mellitus (DM). According to recent studies, a higher frequency of CHC in patients with DM is not associated with this cohort exposure to multiple medical interventions, but with CHC being a possible risk factor for developing DM. CHC m...

ea0019p50 | Clinical practice/governance and case reports | SFEBES2009

Hypomagnesaemia and hypocalcaemia with proton-pump inhibitors: an under-recognised phenomenon

Druce MR , Thomas JDJ , Gorrigan RJ , Kelly PA , Coppack SW , Akker SA

Objectives: We describe three patients recently admitted to our institution with severe hypomagnesaemia and hypocalcaemia and a history of proton pump inhibitor (PPI) therapy.Patient 1 was admitted with lethargy, anorexia and leg cramps. Medications included a PPI (omeprazole) prescribed for gastritis. Corrected calcium was 1.54 mmol/l (2.15–2.65) and magnesium 0.25 mmol/l (0.7–1.0), with a PTH of 1.0 pmol/l (1.6–6.9) and 25-OH-vitamin D 5...

ea0019p249 | Pituitary | SFEBES2009

Exposure to a cocktail of environmental chemicals in sewage sludge: effects on foetal and post pubertal pituitary gonadotrophs in sheep

Bellingham M , McNutt CRE , Fowler PA , Rhind SM , Cotinot C , Sharpe RM , Evans NP

It has been hypothesised that the hypothalamo–pituitary gland complex is a prime target through which environmental chemicals may alter reproductive physiology. The aim of this study was to investigate whether exposure to an environmentally relevant mix of chemicals during in utero and post-natal development can alter pituitary function. Pituitary glands were collected from 110 day-old foetuses (8 control and 8 treated) and 18 month old, post-pubertal sheep (8 cont...

ea0011p901 | Thyroid | ECE2006

Hashimoto’s thyroiditis in the children: clinical features at presentation

Skarpa VT , Kostakioti ED , Tertipi AK , Petrou PA , Posnaghidou E , Anastasakou M , Papahilleos P , Papathanasiou A , Hadjiathanasiou C

Hashimoto’s thyroiditis (HT) is the most frequent thyroid disease in children, in areas of the world with sufficient iodine intake.Aim: To study the clinical features of HT in children at presentation.Material and method: We studied 99 children with HT, 76 (76.8%) girls and 23 (23.2%) boys, with mean chronological age 10.7±2.6 ys (3.2–15.6 ys). The diagnosis of HT was established from the high titers of antithyroid a...

ea0012p46 | Diabetes, metabolism and cardiovascular | SFE2006

A novel syndrome of extreme insulin resistance, primordial dwarfism, and gonadal failure

Semple RK , Finucane F , O’Driscoll M , Regan FM , Soos MA , Stutchfield PR , Davies JH , Dunger DB , Jeggo PA , Nolan JJ , O’Rahilly S

Single gene defects causing severe insulin resistance have been elucidated either by directed screening of candidate genes (INSR, AKT2, PPARG) or by detailed linkage mapping in large pedigrees (BSCL2, AGPAT2, LMNA), and study of patients harbouring these known defects continues to yield important insights into insulin’s action in health and disease. However a large proportion of the genetic defects leading to severe insulin resistance in slim subjects remains undiscovered...

ea0073aep739 | Thyroid | ECE2021

Thyroid cancer detection in routine clinical setting-pilot study

Grimmichova Tereza , Petra Pačesová , Hill Martin , Vaclavikova Eliska , Pekova Barbora , Moravcova Jitka , Vrbikova Jana , Novak Zdenek , Sykorova Vlasta

BackgroundMost thyroid nodules are benign, but therefore it is crucial to correctly stratify the malignancy risk of nodules to avoid unnecessary invasive procedures and/or surgery, but and still identify aggressive tumors. The aim of our study was to address the potential for improvement of malignancy detection in routine clinical setting using clinical examination, risk stratification of thyroid nodules on ultrasound using the American College of Radiol...